IGM Biosciences, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
IGMS on Nasdaq
Industry
Pharmaceutical Preparations
Location
325 E Middlefield Road, Mountain View, CA

Insiders trading volume in the past year

IGM Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jakob Haldor Topsoe Director, 10%+ Owner $121M Sep 30, 2024
Redmile Group, LLC Director, 10%+ Owner $83.1M Sep 30, 2024
Baker Bros. Advisors Lp Director, 10%+ Owner $43.4M +$6.86M +18.8% Sep 30, 2024
Topsoe Holding A/S 10%+ Owner $40.4M Jun 26, 2023
Fred Schwarzer CEO AND PRESIDENT, Director $5.16M -$275K -5.06% Sep 13, 2024
Mary Beth Harler Chief Executive Officer, Director $4.02M -$29.1K -0.72% Oct 2, 2024
Bruce Keyt Chief Scientific Officer $2.85M -$114K -3.83% Sep 13, 2024
Misbah Tahir Chief Financial Officer $2.18M -$90.3K -3.97% Nov 18, 2024
Chris H. Takimoto Chief Medical Officer $1.78M -$90.7K -4.85% Sep 13, 2024
William Strohl Director $1.75M Aug 8, 2024
Lisa Lynn Decker Chief Business Officer $1.16M -$84.5K -6.78% Sep 13, 2024
Daniel ShinYu Chen Chief Medical Officer $769K Jul 1, 2021
Christina Teng Topsoe Director, 10%+ Owner $678K Sep 30, 2024
M. Kathleen Behrens Director $531K Sep 30, 2024
Steven Weber Principal Accounting Officer $372K -$19.1K -4.88% Nov 7, 2024
George Gauthier Chief Commercial Officer $262K -$7.33K -2.73% Nov 29, 2023
Michael D. Loberg Director $231K Sep 29, 2023
Michael Lee Director $108K Sep 30, 2024
Elizabeth H.Z. Thompson Director $50.3K Sep 30, 2024
Julie Hambleton Director $28K -$212K -88.3% Jul 25, 2024

Recent Insider Transactions by Companies or Individuals for IGM Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.